Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Innocan Pharma Corp
C.INNO
Alternate Symbol(s):
INNPF
Healthcare
Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of...
synthetic CBD for non-opioid pain management. In the wellness sector, the Company develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan established a Joint Venture (BI Sky Global Ltd.) that focused on advanced, targeted online sales.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:INNO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(1)
•••
stocksavvy2000
X
View Profile
View Bullboard History
Post by
stocksavvy2000
on Nov 18, 2024 2:33pm
positive FDA engagement
I like this company, I think there can be multiple revenue streams from the LPT-CBD
(5)
•••
edrose
X
View Profile
View Bullboard History
Post by
edrose
on Oct 14, 2024 8:29am
good potential but IF results show safety and effective
it will take years before approval
BioVaxys Partner SpayVac for Wildlife, Inc., Scales-Up Vaccine Production Capacity
posted Nov 20, 2024 9:00am by
BioVaxys Technology Corp.
-
|
Kenneth Kovan, BioVaxys President & Chief Operating Officer, stated, "SpayVac for Wildlife, already a leader in developing breeding control, will leverage its scaled-up capacity to shorten the product-development cycle allowing them to further expand their pipeline using BioVaxys' technology platforms as engines for ...read more
(15)
•••
realistic25
X
View Profile
View Bullboard History
Post by
realistic25
on Oct 12, 2024 3:41pm
Excellente opportunité pour investisseur
Derniere nouvelle: https://www.medicaldaily.com/professor-chezy-barenholz-cbd-powered-revolution-pharmaceuticals-466088
(15)
•••
realistic25
X
View Profile
View Bullboard History
Post by
realistic25
on Oct 12, 2024 3:26pm
An investor's opportunity in injectable liposomal CBD's pote
LOOK : https://stockhouse.com/news/newswire/2024/10/10/an-investor-s-opportunity-injectable-liposomal-cbd-s-potential
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Sep 03, 2024 9:28pm
Advances Liposomal CBD with Positive Response from FDA
HERZLIYA, Israel and CALGARY, Alberta, Sept. 3, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company")
...more
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Aug 25, 2023 6:59pm
Innocan Pharma Reports Q2 2023 Results
US$3.121M Revenues for Q2, 2023 compared to US$415,000 for Q2 2022, representing an increase of 652% US$2.656M Gross Profit for Q2, 2023 compared to USD 214,000 for
...more
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Comment by
Betteryear2
on Jul 25, 2023 8:53pm
RE: Private Placement of Units at a 9% Prime Above Share Price
Note: There appears to be an error in release. It states: The Offering is expected to close on or around July 20, 2023. The reader should also be aware that it has not yet been posted in
...more
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jul 25, 2023 8:46pm
Private Placement of Units at a 9% Prime Above Share Price
HERZLIYA, Israel, and CALGARY, Alberta, July 25, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan
...more
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Apr 29, 2022 9:03am
Innocan Pharma's Compassionate Care Treatment for Dogs
A Case Report Published in Frontiers in Veterinary Science Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)
...more
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Apr 11, 2022 4:04pm
Innocan Pharma's Case Report Accepted
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased
...more
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jan 17, 2022 4:13pm
Inauguration of Its Drug Development Lab
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is
...more
(1)
•••
dkeller85
X
View Profile
View Bullboard History
Post by
dkeller85
on Jan 11, 2022 8:33am
Why this Canadian-Israeli Stock Grew 121% This Year
"Innocan Pharma operates three primary and distinct segments: research and development (R&D) of CBD-loaded exosomes, R&D of the use of CBD-loaded liposomes, and commercialization and sale
...more
(239)
•••
Charly50
X
View Profile
View Bullboard History
Post by
Charly50
on Nov 24, 2021 12:19pm
Distributers and investors
Our CEO Iris Bincovich reports back from Canada. She achieved: Meetings and soft commitments from distributers and investors and positivite feedbacks from pharma experts. More to follow soon via
...more
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Nov 18, 2021 4:31pm
Successful Demonstration of Prolonged Release of CBD in Dogs
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is
...more
(239)
•••
Charly50
X
View Profile
View Bullboard History
Post by
Charly50
on Nov 17, 2021 12:50pm
https://www.wallstreet-online.de/nachricht/14682875-innocan-
Innocan Pharma wird auf der Lift & Co. Expo am 19. November 2021 an einer Podiumsdiskussion zum Thema Unternehmenswachstum teilnehmen
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden